Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 18,385 | 170,627 | 4,957 | 4,851 | 5,206 |
| Operating Income | -18,385 | -170,627 | -4,957 | -4,851 | -5,206 |
| Interest Expense | 0 | 0 | 26 | 6 | 0 |
| Other Income | 2,378 | 391 | 267 | 288 | 270 |
| Pre-tax Income | -16,007 | -170,236 | -4,716 | -4,569 | -4,936 |
| Net Income Continuous | -16,007 | -170,236 | -4,716 | -4,569 | -4,936 |
| Net Income | $-16,007 | $-170,236 | $-4,716 | $-4,569 | $-4,936 |
| EPS Basic Total Ops | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| EPS Basic Continuous Ops | -2.84 | -131.45 | -3.73 | -3.62 | -3.91 |
| EPS Diluted Total Ops | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| EPS Diluted Continuous Ops | -2.84 | -131.45 | -3.73 | -3.62 | -3.91 |
| EPS Diluted Before Non-Recurring Items | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| EBITDA(a) | $-18,360 | $-170,597 | $-4,923 | $-4,817 | $-5,169 |